Rheumatoid arthritis

Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction?

Scand J RheumatolPublished Retrospective cohort study

Authors' conclusion

Anti-inflammatory treatment was not associated with mortality within 30 days after a first AMI. From 31 to 365 days post-AMI, corticosteroid treatment was associated with increased mortality risk for all patients, and csDMARDs and anti-TNFs were associated with increased survival for RA patients.

Study context

Population
Patients with a first acute myocardial infarction (AMI) during 2006–2017, Swedish registries; drugs categorised as corticosteroids, NSAIDs, csDMARDs, anti-TNFs or other bDMARDs3,725 rheumatoid arthritis (RA) patients
Participants
199,071 patients
Exposure
Anti-inflammatory treatment in the 6 months before a first AMI vs no such treatment, in patients with and without RA
  • RAn = 3,725
Outcome
Mortality (survival) after first AMI by anti-inflammatory treatment
Follow-up
Up to 365 days post-AMI
Methodological detailsSwedish registries, multivariable logistic regression (≤30 days), multivariable Cox proportional hazard models (31–365 days)
  • Swedish registries
  • Multivariable logistic regression (≤30 days)
  • Multivariable Cox proportional hazard models (31–365 days)

Main finding

As reported in the abstract

Mortality, 31 to 365 days post-AMI
Hazard ratio (95% CI)
Corticosteroids (RA)increased mortality
1.43(1.27–1.62)
Corticosteroids (without RA)increased mortality
1.37(1.33–1.41)
csDMARDs (RA)increased survival
0.86(0.78–0.96)
Anti-TNFs (RA)increased survival
0.72(0.56–0.94)
csDMARDs (without RA)increased mortality
1.14(1.04–1.24)

Observational data: associations, not effects.

Further findings

No treatment was associated with survival within 30 days after the AMI

Original publication

Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction? Scand J Rheumatol. Published 29 August 2025. doi:10.1080/03009742.2025.2544409

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.